Anti-tumor necrosis factor drug survival in axial spondyloarthritis is independent of the classification criteria. - Zufferey, Pascal; Ghosn, Jacqueline; Becce, Fabio; Ciurea, Adrian; Aubry-Rozier, Bérengère; Finckh, Axel; So, Alexander (Rheumatology International, 2015)